Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eac42330438996748709e8916c62c292 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-433 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-433 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52 |
filingDate |
1999-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0d15c04ab0587b49b8801fe7bc403fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb464762ef0600f29a6061d34f726a28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc6df0be44171e6106cb0bd414312bd5 |
publicationDate |
2000-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-0013675-A1 |
titleOfInvention |
Methazolamide compositions and method of use |
abstract |
A pharmaceutical composition useful for treating ocular conditions, such as glaucoma. In particular, the pharmaceutical composition is a sustained release oral dosage composition for relieving intraocular pressure comprising methazolamide and a high molecular weight binder, wherein the composition provides sustained rate of methazolamide release in an in vitro drug release profile. A filler and a lubricant may also be included. |
priorityDate |
1998-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |